Symbol
|
XWQLTQ | RNOAGV | ZMFLTQ | ZKYLTQ |
---|---|---|---|---|
Nom | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible |
Sous-jacent
|
Eli Lilly & Co. / Novo Nordisk AS (B) / Pfizer Inc. Basket | Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Pfizer Inc. Basket | Novo Nordisk AS (B) |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
Échéance
|
27.12.2024 | 29.01.2025 | 08.10.2025 | 22.03.2027 |
Ratio | - | 0,726602 | - | 0,9055 |
Prix d'exercise
|
- | - | - | - |
rendement max. p.a. | 7,20% | 5,30% | 10,25% | 7,81% |
Demande | 100,67 | 100,70 | 98,88 | 99,06 |
Offre | 101,48 | 101,70 | 99,68 | 99,86 |